Vultaggio Vincent 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Vultaggio Vincent
PAO and PFO
Transactions
- Sale
Common Stock
2024-10-04$3.18/sh−1,603$5,098→ 33,855 total
Footnotes (1)
- [F1]A portion of the shares were sold automatically to satisfy withholding tax obligations upon the vesting of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on September 20, 2023.